Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC

Phase 2

Active, not recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Procedure: Surgery
Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2012-12-20

Last Posted Date: 2025-01-06

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 44

Registration Number: NCT01753414

Locations: 🇨🇳
Chinese Academy of Medical Science, Beijing, China
🇨🇳
Shandong Cancer Hospital, Jinan, Shangdong, China
🇨🇳
Shanghai Cancer Center/Fudan University, Shanghai, China

and more 1 locations

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Phase 3

Active, not recruiting

Conditions: Advanced Adult Primary Liver Cancer
Adult Primary Hepatocellular Carcinoma
Recurrent Adult Primary Liver Cancer

Interventions: Drug: Sorafenib
Radiation: stereotactic body radiation therapy

First Posted Date: 2012-11-21

Last Posted Date: 2025-02-07

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 193

Registration Number: NCT01730937

Locations: 🇺🇸
Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
UCSF Medical Center-Mount Zion, San Francisco, California, United States

and more 48 locations

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Phase 2

Completed

Conditions: Adult Glioblastoma
Recurrent Adult Brain Tumor
Adult Giant Cell Glioblastoma
Adult Gliosarcoma

Interventions: Biological: bevacizumab
Radiation: radiation therapy

First Posted Date: 2012-11-21

Last Posted Date: 2022-12-29

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 182

Registration Number: NCT01730950

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States
🇺🇸
Arizona Oncology-Deer Valley Center, Phoenix, Arizona, United States

and more 28 locations

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

Phase 2

Completed

Conditions: Non-HPV Locally Advanced Head and Neck Cancer

Interventions: Radiation: IMRT
Drug: Cisplatin
Drug: placebo
Drug: Lapatinib

First Posted Date: 2012-10-22

Last Posted Date: 2023-10-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 142

Registration Number: NCT01711658

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸
Sutter General Hospital, Sacramento, California, United States

and more 13 locations

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Phase 3

Completed

Conditions: Perioperative/Postoperative Complications
Gastrointestinal Complications
Cervical Cancer
Endometrial Cancer
Radiation Toxicity
Urinary Tract Toxicity
Urinary Complications

Interventions: Radiation: intensity-modulated radiation therapy
Radiation: Standard radiation therapy

First Posted Date: 2012-08-27

Last Posted Date: 2022-06-15

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 289

Registration Number: NCT01672892

Locations: 🇺🇸
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸
Arizona Oncology-Deer Valley Center, Phoenix, Arizona, United States
🇺🇸
Arizona Oncology Services Foundation, Scottsdale, Arizona, United States

and more 134 locations

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: GnRH agonist
Drug: Anti-androgen
Drug: TAK-700
Radiation: Radiation therapy

First Posted Date: 2012-03-07

Last Posted Date: 2023-04-18

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 239

Registration Number: NCT01546987

Locations: 🇺🇸
The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Arizona Oncology-Deer Valley Center, Phoenix, Arizona, United States

and more 169 locations

Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer
Radiation Toxicity
Sexual Dysfunction
Psychosocial Effects of Cancer and Its Treatment

Interventions: Radiation: 51.6 Gy IMRT
Radiation: 36.25 Gy IMRT

First Posted Date: 2011-09-14

Last Posted Date: 2022-06-09

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 255

Registration Number: NCT01434290

Locations: 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Arizona Center for Cancer Care - Peoria, Peoria, Arizona, United States
🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States

and more 34 locations

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

Completed

Conditions: Adult Diffuse Astrocytoma
Neurotoxicity
Psychosocial Effects of Cancer and Its Treatment
Seizure
Adult Mixed Glioma
Adult Oligodendroglioma
Cognitive/Functional Effects

Interventions: Procedure: cognitive assessment
Procedure: magnetic resonance imaging
Other: laboratory biomarker analysis
Other: questionnaire administration
Procedure: quality-of-life assessment

First Posted Date: 2011-08-16

Last Posted Date: 2015-03-18

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 82

Registration Number: NCT01417507

Locations: 🇺🇸
The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Providence Hospital, Mobile, Alabama, United States

and more 38 locations

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2

Completed

Conditions: Neurotoxicity
Radiation Toxicity
Chemotherapeutic Agent Toxicity
Cognitive/Functional Effects
Lymphoma

Interventions: Biological: Rituximab
Drug: Cytarabine
Drug: Methotrexate
Drug: Procarbazine
Drug: Vincristine
Radiation: low-dose whole-brain radiation therapy

First Posted Date: 2011-07-21

Last Posted Date: 2023-07-20

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 91

Registration Number: NCT01399372

Locations: 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸
The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States
🇺🇸
Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

and more 42 locations

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: radiation therapy
Radiation: Whole-pelvic radiotherapy (WPRT)

First Posted Date: 2011-06-08

Last Posted Date: 2023-08-16

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 2592

Registration Number: NCT01368588

Locations: 🇺🇸
University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
🇺🇸
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
🇺🇸
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States

and more 474 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy